Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Recurrence After Radical Prostatectomy (SHARE Trial): a Prospective, Randomized Controlled, Open-label, Multi Center, Superiority Study

NCT03920033 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT03920033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03920033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Recurrence After Radical Prostatectomy (SHARE Trial): a Prospective, Randomized Controlled, Open-label, Multi Center, Superiority Study
Lead sponsor
Asan Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
May 1, 2019
Completion date
January 1, 2027
Enrollment
288 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

biochemical recurrence, dose escalation, hypofractionation, prostate cancer, quality of life, radiation, radiation toxicity, survival